Research output per year
Research output per year
Fingerprint
Dive into the research topics where Kazuki Takada is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
ASO Visual Abstract: Significance of Tumor Microvasculature in the Tumor Microenvironment in Adenocarcinoma with EGFR Common Mutation
Matsudo, K., Takada, K., Hashinokuchi, A., Nagano, T., Kinoshita, F., Akamine, T., Kohno, M., Takenaka, T., Shimokawa, M., Oda, Y. & Yoshizumi, T., Jun 1 2025, In: Annals of Surgical Oncology. 32, 6, p. 4207-4208 2 p.Research output: Contribution to journal › Article › peer-review
-
CD155 expression and co-expression with PD-L1 are not associated with poor prognosis in patients with stage II and III lung adenocarcinoma undergoing surgical resection
Matsudo, K., Takada, K., Hashinokuchi, A., Nagano, T., Kinoshita, F., Akamine, T., Kohno, M., Takenaka, T., Shimokawa, M., Oda, Y. & Yoshizumi, T., 2025, (Accepted/In press) In: International Journal of Clinical Oncology. e128633.Research output: Contribution to journal › Article › peer-review
-
Clinical significance of CD155 expression in surgically resected lung squamous cell carcinoma
Nagano, T., Takada, K., Hashinokuchi, A., Matsudo, K., Kinoshita, F., Akamine, T., Kohno, M., Shimokawa, M., Takenaka, T., Oda, Y. & Yoshizumi, T., Jan 2025, In: International Journal of Clinical Oncology. 30, 1, p. 62-71 10 p., e004219.Research output: Contribution to journal › Article › peer-review
1 Citation (Scopus) -
Corrigendum to ‘MUC1-C Is a Common Driver of Acquired Osimertinib Resistance in NSCLC’ [Journal of Thoracic Oncology 19 Issue 3 (2024) 434-450, (S1556086423023481), (10.1016/j.jtho.2023.10.017)]
Haratake, N., Ozawa, H., Morimoto, Y., Yamashita, N., Daimon, T., Bhattacharya, A., Wang, K., Nakashoji, A., Isozaki, H., Shimokawa, M., Kikutake, C., Suyama, M., Hashinokuchi, A., Takada, K., Takenaka, T., Yoshizumi, T., Mitsudomi, T., Hata, A. N. & Kufe, D., Mar 2025, In: Journal of Thoracic Oncology. 20, 3, p. 399 1 p.Research output: Contribution to journal › Comment/debate › peer-review
-
Determinants of 5-year survival in patients with advanced NSCLC with PD-L1≥50% treated with first-line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry
Cortellini, A., Brunetti, L., Di Fazio, G. R., Garbo, E., Pinato, D. J., Naidoo, J., Katz, A., Loza, M., Neal, J. W., Genova, C., Gettinger, S., Kim, S. Y., Jayakrishnan, R., El Zarif, T., Russano, M., Pecci, F., Di Federico, A., Awad, M., Alessi, J. V. & Montrone, M. & 87 others, , Feb 4 2025, In: Journal for immunotherapy of cancer. 13, 2, e010674.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus)